XML 62 R50.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information - Schedule of Segment Loss (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]    
Total operating expenses $ 17,341 $ 16,883
Loss from operations (17,341) (16,883)
Net loss (15,758) (15,430)
Operating Segments    
Segment Reporting Information [Line Items]    
Facilities related expense 2,299 652
Stock-based compensation and depreciation 2,114 1,590
Total operating expenses 17,341 16,883
Loss from operations (17,341) (16,883)
Interest and other income, net 1,583 1,453
Net loss (15,758) (15,430)
Research and Development | Operating Segments    
Segment Reporting Information [Line Items]    
Compensation and benefits expenses [1] 3,294 3,487
Clinical trial costs 2,850 2,596
Outsourced services and Consulting 2,382 4,679
Lab and pharmacology supplies 290 704
Other costs [2] 597 433
General and Administrative Expenses | Operating Segments    
Segment Reporting Information [Line Items]    
Compensation and benefits expenses [1] 1,574 1,547
Professional service fees 997 793
Insurance 218 30
Other Costs [3] $ 726 $ 372
[1] Excludes stock-based compensation expense.
[2] Includes software expense, database subscriptions expense, lab service contract expense, travel expense, and other miscellaneous expenses.
[3] Includes travel expense, public & investor relations expense, software expense, employee training & development expense, and other miscellaneous expenses.